Lupin Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Lupin Pharmaceuticals's estimated annual revenue is currently $1B per year.
- Lupin Pharmaceuticals's estimated revenue per employee is $222,003
Employee Data
- Lupin Pharmaceuticals has 4718 Employees.
- Lupin Pharmaceuticals grew their employee count by 10% last year.
Lupin Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
2 | Officer | Reveal Email/Phone |
3 | EVP Commercial Operations, US Generics | Reveal Email/Phone |
4 | VP, R&D | Reveal Email/Phone |
5 | SVP, Global Business Development & Portfolio - Biologics | Reveal Email/Phone |
6 | VP - Marketing, Pricing & Analytics | Reveal Email/Phone |
7 | Sr. Director Human Resources | Reveal Email/Phone |
8 | Associate Director, Quality | Reveal Email/Phone |
9 | Director, Corporate Counsel | Reveal Email/Phone |
10 | Associate Director, Supply Chain | Reveal Email/Phone |
Lupin Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7M | 26 | -10% | N/A | N/A |
#2 | N/A | 11 | 0% | N/A | N/A |
#3 | $7.2M | 28 | -7% | N/A | N/A |
#4 | $10.5M | 24 | -44% | N/A | N/A |
#5 | $344.1M | 1667 | 18% | N/A | N/A |
#6 | $27.5M | 123 | 9% | N/A | N/A |
#7 | $107.3M | 524 | 19% | N/A | N/A |
#8 | $12.9M | 64 | 28% | N/A | N/A |
#9 | $31.6M | 145 | 4% | N/A | N/A |
#10 | $31.4M | 125 | -3% | N/A | N/A |
What Is Lupin Pharmaceuticals?
Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top five pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.
keywords:N/A
N/A
Total Funding
4718
Number of Employees
$1B
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lupin Pharmaceuticals News
Lupin Pharmaceuticals; ROSEMONT Pharma; Merck KGaA; Breckenridge Pharmaceutical; Amneal; Upsher-Smith; Hikma. Clobazam Market Breakdown by Type: 10mg...
"Plaintiffs Arbor Pharmaceuticals LLC and Takeda Pharmaceutical Co. Ltd., and defendants Lupin Ltd. and Lupin Pharmaceuticals Inc.,...
Lupin's active pharmaceutical ingredient (API) plant in Tarapur, India, has been slapped with a Form 483, the company confirmed (PDF) in a filing.
Drug major Lupin today said it has received approval from its shareholders to raise up to Rs 7,500 crore through issue of securities. In a BSE filing, the Mumbai-based firm said shareholders have approved a proposal today “to raise funds for an amount not exceeding Rs 7,500 crore through issue ...
Other Companies in Baltimore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1911.5M | 5057 | 4% | N/A |
#2 | $1301.3M | 5164 | N/A | N/A |
#3 | $75M | 5400 | 5% | N/A |
#4 | $300M | 5983 | 7% | N/A |
#5 | $3184.3M | 6629 | 2% | N/A |